论文信息 - Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL - 字舞流文

Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL

E. González-Barca | A. Avilion | C. Thieblemont | M. Chu | A. Viardot | M. Bastos-Oreiro | Yuliya Katlinskaya | Yuqi Chen | A. Anderson | K. David | Seung Tae Lee | H. Wong | N. Morley | A. Martín García-Sancho | T. Dai | J. Morris | W. Kormany | D. Katz | Sharif S. Khan | Guillermo Rodríguez-García | S. T. Lee | Yuliya V Katlinskaya